Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Trading Statement

23 Jul 2025 07:00

RNS Number : 1038S
Wilmington PLC
23 July 2025
Β 

23 July 2025

Wilmington plc

Β 

Year-end trading update

Β 

Wilmington plc, (LSE: WIL, 'Wilmington', 'the Group') the provider of data, information, education and training in the global Governance, Risk and Compliance ('GRC') markets, today provides a trading update for the year ended 30 June 2025.

Β 

Revenue growth from the Group's ongoing* businesses is expected to be 11%, led by both recent acquisitions in the HSE sector delivering double-digit percentage growth.

Β 

As at the half year, seven out of nine businesses grew year on year. Following the portfolio changes last year of two disposals and two acquisitions, and the continuing disruption in the US healthcare insurance market impacting our US events business over a full year, reported revenue is expected to be Β£101.5m (2024: Β£126m), with organic** revenue also having decreased 1% due to the US.

Β 

Operating profit from ongoing* businesses is expected to be up 11%, adjusted*** profit before tax is expected to be Β£27.7m (2024: Β£27.6m), with adjusted PBT margin up to 27% (2024: 22%).

Β 

Cash conversion continued to be strong at 107% of profits, with Group net cash on 30 June 2025 at Β£41.9m (30 June 2024: Β£67.8m) after the completion of the acquisition of Phoenix Health & Safety on 25 October 2024 and spending Β£3.4m on share buybacks.

Β 

Wilmington expects to publish its year end results on 22 September 2025.

Β 

Mark Milner, Chief Executive Officer, commented:

Β 

"We have seen another year of good ongoing* revenue and profit growth with both measures increasing 11%, reflecting our focus on a slimmed down higher quality portfolio of growing businesses. Margins have also continued to improve and both of our recent acquisitions have seen double digit growth. This performance came against a tough macro backdrop, particularly in the US healthcare market which has seen continued disruption in the course of our H2.

Β 

"With the acquisition of Phoenix, we have continued to actively manage our portfolio of businesses and are pursuing various opportunities to invest our cash in acquisitions to improve the quality of revenue and profits."

Β 

*Ongoing - eliminating the effects of the impact of disposals, closures and businesses held for sale.

**Organic - Ongoing, eliminating acquisitions and exchange rate fluctuations

***Adjusted profit before tax (PBT) is calculated as PBT after adding back amortisation and impairment of intangible assets (except computer software) and profits/losses on disposals and business closures. Market consensus adjusted profit before tax is Β£27.0m.

Β 

For further information, please contact:

Β 

Wilmington plc

Mark Milner, Chief Executive Officer

Guy Millward, Chief Financial Officer

Β 

Meare Consulting

Adrian Duffield

Β 

Β 

020 7490 0049

Β 

Β 

Β 

Β 

07990 858548

Β 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

Β 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs around 600 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTUUUORVWUBUAR
Date   Source Headline
3rd Nov 20217:00 amRNSAGM Statement
1st Nov 20217:00 amRNSTotal Voting Rights
15th Oct 20213:54 pmRNSHolding(s) in Company
14th Oct 202111:05 amRNSHolding(s) in Company
8th Oct 20214:40 pmRNSSecond Price Monitoring Extn
8th Oct 20214:35 pmRNSPrice Monitoring Extension
1st Oct 20217:00 amRNSDirector/PDMR Shareholding
20th Sep 20217:00 amRNSFinancial results for year ended 30 June 2021
7th Sep 202111:21 amRNSHolding(s) in Company
26th Aug 20217:00 amRNSNotification of Final Results
5th Aug 20212:58 pmRNSHolding(s) in Company
3rd Aug 202112:20 pmRNSEmployee Share Ownership Trust Purchase
2nd Aug 202112:40 pmRNSTotal Voting Rights
30th Jul 202111:11 amRNSEmployee Share Ownership Trust Purchase
20th Jul 20217:00 amRNSYear-end Trading Update
19th Jul 202110:57 amRNSEmployee Share Ownership Trust Purchase
5th Jul 20215:06 pmRNSEmployee Share Ownership Trust Purchase
1st Jul 20218:52 amRNSTotal Voting Rights
29th Jun 202111:49 amRNSEmployee Share Ownership Trust Purchase
28th Jun 20214:40 pmRNSSecond Price Monitoring Extn
28th Jun 20214:35 pmRNSPrice Monitoring Extension
18th Jun 202111:33 amRNSEmployee Share Ownership Trust Purchase
10th Jun 20217:00 amRNSNew group structure and operating model
8th Jun 20213:00 pmRNSDuplicate Announcement
4th Jun 202111:16 amRNSEmployee Share Ownership Trust Purchase
4th Jun 202111:11 amRNSEmployee Share Ownership Trust Purchase
1st Jun 20215:14 pmRNSEmployee Share Ownership Trust Purchase
27th May 20213:25 pmRNSDirector/PDMR Shareholding
11th May 20213:08 pmRNSEmployee Share Ownership Trust Purchase
21st Apr 20211:48 pmRNSHolding(s) in Company
25th Mar 20217:00 amRNSHolding(s) in Company
1st Mar 20217:00 amRNSDirector Shareholding
1st Mar 20217:00 amRNSVoting Rights and Capital
18th Feb 20217:00 amRNSWilmington plc - Interim Results
20th Jan 20217:00 amRNSDirectorate Change
14th Jan 20212:15 pmRNSHolding(s) in Company
21st Dec 202011:49 amRNSDirector/PDMR Shareholding
25th Nov 20204:41 pmRNSSecond Price Monitoring Extn
25th Nov 20204:36 pmRNSPrice Monitoring Extension
4th Nov 202012:43 pmRNSResult of AGM
4th Nov 20207:00 amRNSTrading Statement
20th Oct 202012:09 pmRNSSAYE and Director/PDMR Shareholding
12th Oct 20207:00 amRNSDirectorate Change
1st Oct 20209:42 amRNSDirector/PDMR Shareholding
17th Sep 20204:27 pmRNSWilmington plc - Share Awards
17th Sep 20207:00 amRNSPreliminary Results
3rd Sep 202011:27 amRNSHolding(s) in Company
21st Aug 20206:09 pmRNSHolding(s) in Company
21st Aug 202011:30 amRNSHolding(s) in Company
19th Aug 20207:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.